(±)-Evodiamine is primarily studied for its potential therapeutic applications in various fields of medicine. It has shown promise as an anti-cancer agent due to its ability to inhibit the proliferation of cancer cells and induce apoptosis. Research suggests it may be effective against certain types of tumors, including breast, colon, and liver cancers, by targeting specific signaling pathways involved in cell growth and survival. Additionally, (±)-evodiamine has been explored for its anti-inflammatory and analgesic properties, making it a candidate for managing chronic pain and inflammatory conditions. It also exhibits potential in weight management, as it may enhance thermogenesis and fat metabolism, offering benefits for obesity-related disorders. Further studies are ongoing to fully understand its mechanisms and optimize its use in clinical settings.